Philippa Griffin

Philippa has a substantial prosecution practice before the European Patent Office (EPO), and she is responsible for the coordination and strategic management of complex worldwide patent portfolios covering commercially significant products. Philippa is also highly experienced in the conduct of offensive and defensive opposition and appeal proceedings before the EPO. Other aspects of her practice include drafting, freedom to operate, and opinion work.

Philippa has particular expertise in handling inventions relating to antibodies and immunology; immunotoxin-based therapeutics; recombinant protein production and formulation; synthetic biology, gene editing, cloning, and sequencing technologies; rapid/bedside diagnostics; modified and thermostable enzymes; bone and cartilage regeneration; and vaccines. She acts for a diverse range of clients, including international biopharma and bioscience companies, SMEs, public sector organisations, and universities.

Philippa studied at Cambridge University, obtaining a first class master’s degree in natural sciences (zoology), and also holds a Certificate in Intellectual Property Law from the University of London.

Philippa is a member of the Chartered Institute of Patent Attorneys (CIPA) and European Patent Institute (EPI), and serves as a lecturer for the CIPA Foundation Examinations.